Friday, July 10, 2026

pharma · No medical condition. · Breast cancer

George Institute for

George Institute is a pharma organization headquartered in KOLKATA, IN. Primary therapeutic focus areas include No medical condition., Breast cancer, Metastatic colorectal cancer, Prostate Cancer, advanced/metastatic HER

Sydney, NSW 2042, AU HQ
1999 Founded
841 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Sydney, NSW 2042, AU
Founded
1999
Employees
841
Programs
406
Drugs
522
Patents
0
Clinical program

TESTOGEL for low ovarian reserve according t…

Approved · small molecule · low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

TESTOGEL for low ovarian reserve according t… for low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

← All The George Institute projects Approved small molecule active

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
The George Institute
Phase
Approved
Modality
small_molecule
Indication
low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism
Status
active
Trials
1